Detection and Response to an HIV Cluster: People Living Homeless and Using Drugs in Seattle, Washington.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
11 2021
Historique:
received: 23 02 2021
revised: 21 04 2021
accepted: 28 04 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 6 11 2021
Statut: ppublish

Résumé

The HIV epidemic in King County, Washington has traditionally been highly concentrated among men who have sex with men, and incidence has gradually declined over 2 decades. In 2018, King County experienced a geographically concentrated outbreak of HIV among heterosexual people who inject drugs. Data sources to describe the 2018 outbreak and King County's response were partner services interview data, HIV case reports, syringe service program client surveys, hospital data, and data from a rapid needs assessment of homeless individuals and people who inject drugs. In 2020, the authors examined the impact of delays in molecular sequence analyses and cluster member size thresholds, for identifying genetically similar clusters, on the timing of outbreak identification. In 2018, the health department identified a North Seattle cluster, growing to 30 people with related HIV infections diagnosed in 2008-2019. In total, 70% of cluster members were female, 77% were people who inject drugs, 87% were homeless, and 27% reported exchanging sex. Intervention activities included a rapid needs assessment, 2,485 HIV screening tests in a jail and other outreach settings, provision of 87,488 clean syringes in the outbreak area, and public communications. A lower cluster size threshold and more rapid receipt and analyses of data would have identified this outbreak 4-16 months earlier. This outbreak shows the vulnerability of people who inject drugs to HIV infection, even in areas with robust syringe service programs and declining HIV epidemics. Although molecular HIV surveillance did not identify this outbreak, it may have done so with a lower threshold for defining clusters and more rapid receipt and analyses of HIV genetic sequences.

Identifiants

pubmed: 34686286
pii: S0749-3797(21)00362-7
doi: 10.1016/j.amepre.2021.04.037
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

S160-S169

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI127232
Pays : United States

Informations de copyright

Copyright © 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Susan E Buskin (SE)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington. Electronic address: susan.buskin@kingcounty.gov.

Steven J Erly (SJ)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; Office of Infectious Disease, Division of Disease Control and Health Statistics, Washington State Department of Health, Tumwater, Washington.

Sara N Glick (SN)

HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.

Richard J Lechtenberg (RJ)

HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington.

Roxanne P Kerani (RP)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.

Joshua T Herbeck (JT)

Department of Global Health, University of Washington, Seattle, Washington.

Julia C Dombrowski (JC)

HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.

Amy B Bennett (AB)

HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington.

Francis A Slaughter (FA)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington.

Michael P Barry (MP)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington.

Santiago Neme (S)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington; University of Washington Medical Center - Northwest, Seattle, Washington.

Laura Quinnan-Hostein (L)

University of Washington Medical Center - Northwest, Seattle, Washington; Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington.

Andrew Bryan (A)

University of Washington Medical Center - Northwest, Seattle, Washington; Department of Laboratory Medicine & Pathology, University of Washington Medicine, University of Washington, Seattle, Washington.

Matthew R Golden (MR)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; HIV/STD Program, Prevention Division, Public Health-Seattle & King County, Seattle, Washington; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH